OTTAWA, May 17, 2018 /CNW/ - Annidis Corporation (TSX Venture: RHA) ("Annidis" or the "Corporation"), announces that it received the suspension and reinstatement to trading – notice transfer to NEX from TSX Venture Exchange.
The notice says, this will confirm that effective May 4, 2018; the TSX Venture Exchange (the "Exchange") suspended trading in the Company's securities as a result of a Cease Trade Order issued by the Ontario Securities Commission. A copy of the Exchange bulletin can be obtained from our website at tmx.com. Reinstatement to trading can occur only when the Cease Trade Order is revoked and the Exchange has concluded its reinstatement review to ensure the Company has satisfactorily complied with Exchange requirement.
About Annidis Corporation
Annidis (TSX-V: RHA) has developed, manufactures and sells a patented imaging platform technology based on multi-spectral imaging. The current RHA is a retinal screening technology used by primary care professionals for early disease detection. The RHA is complementary to diagnostic imaging technologies and supports the timely identification, treatment and monitoring of a wide range of vision threatening diseases.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain statements in this press release are forward looking statements and are prospective in nature, including statements with respect to the prospect of the Corporation finding a solution to its current financial situation or finding a potential strategic partner or investor. Forward‐looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward‐looking statements. These statements generally can be identified by the use of forward‐looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Such forward‐looking statements should therefore be construed in light of such factors, and the Corporation is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise.
SOURCE Annidis Corporation
For further information: Ying Gu, Director, Annidis Corporation, 613 596-1800